Skip to main content

Cholinoceptor Agonists and Anticholinesterase Agents

  • Chapter
  • First Online:
Introduction to Basics of Pharmacology and Toxicology

Abstract

The parasympathetic system (cholinergic system) is responsible for the conservation of energy, digestion, and growth. Acetylcholine is the major neurotransmitter of the parasympathetic system acting on muscarinic and nicotinic receptors. The cholinergic system can be directly stimulated by natural alkaloids like muscarine and nicotine, indirectly by inhibiting cholinesterase enzyme with carbamates. Toxins like bungarotoxins, conotoxin, and botulinum toxin inhibit cholinergic neurotransmission. Modulation of acetylcholine level by various acetylcholinesterase inhibitors plays a pivot role in the management of neurodegenerative disorders like Alzheimer’s disease, glaucoma, snakebite envenomation, and others. Understanding the mechanism of inhibition of acetylcholinesterases by organophosphorus compounds, carbamates, and nerve gases has led to successful pharmacological management of poisoning by these compounds. This chapter will review the synthesis and secretion of ACh, its receptors and actions brought out by the cholinergic system with details about the drugs that modulate the cholinergic system for the benefit in various clinical conditions.

This is a preview of subscription content, log in via an institution to check access.

Access this chapter

Chapter
USD 29.95
Price excludes VAT (USA)
  • Available as PDF
  • Read on any device
  • Instant download
  • Own it forever
eBook
USD 189.00
Price excludes VAT (USA)
  • Available as EPUB and PDF
  • Read on any device
  • Instant download
  • Own it forever
Softcover Book
USD 249.99
Price excludes VAT (USA)
  • Compact, lightweight edition
  • Dispatched in 3 to 5 business days
  • Free shipping worldwide - see info
Hardcover Book
USD 249.99
Price excludes VAT (USA)
  • Durable hardcover edition
  • Dispatched in 3 to 5 business days
  • Free shipping worldwide - see info

Tax calculation will be finalised at checkout

Purchases are for personal use only

Institutional subscriptions

Bibliography

  • Carnevali L, Sgoifo A (2014) Vagal modulation of resting heart rate in rats: the role of stress, psychosocial factors, and physical exercise. Front Physiol 5:118

    Article  Google Scholar 

  • Conn PJ, Jones CK, Lindsley CW (2009) Subtype-selective allosteric modulators of muscarinic receptors for the treatment of CNS disorders. Trends Pharmacol Sci 30(3):148–155

    Article  CAS  Google Scholar 

  • Eddleston M, Chowdhury FR (2016) Pharmacological treatment of organophosphorus insecticide poisoning: the old and the (possible) new. Br J Clin Pharmacol 81(3):462–470

    Article  CAS  Google Scholar 

  • Eddleston M, Eyer P, Worek F, Juszczak E, Alder N, Mohamed F et al (2009) Pralidoxime in acute organophosphorus insecticide poisoning--a randomised controlled trial. PLoS Med 6(6):e1000104

    Article  Google Scholar 

  • Eglen RM, Hegde SS, Watson N (1996) Muscarinic receptor subtypes and smooth muscle function. Pharmacol Rev 48(4):531–565

    CAS  PubMed  Google Scholar 

  • Felder CC, Bymaster FP, Ward J, DeLapp N (2000) Therapeutic opportunities for muscarinic receptors in the central nervous system. J Med Chem 43(23):4333–4353

    Article  CAS  Google Scholar 

  • Köppel C (1993) Clinical symptomatology and management of mushroom poisoning. Toxicon 31(12):1513–1540

    Article  Google Scholar 

  • Kruse AC, Hu J, Pan AC, Arlow DH, Rosenbaum DM, Rosemond E et al (2012) Structure and dynamics of the M3 muscarinic acetylcholine receptor. Nature 482(7386):552–556

    Article  CAS  Google Scholar 

  • Langmead CJ, Watson J, Reavill C (2008) Muscarinic acetylcholine receptors as CNS drug targets. Pharmacol Ther 117(2):232–243

    Article  CAS  Google Scholar 

  • Lanzafame AA, Christopoulos A, Mitchelson F (2003) Cellular signaling mechanisms for muscarinic acetylcholine receptors. Recept Channels 9(4):241–260

    Article  CAS  Google Scholar 

  • Matsui M, Motomura D, Fujikawa T, Jiang J, Takahashi S, Manabe T et al (2002) Mice lacking M2 and M3 muscarinic acetylcholine receptors are devoid of cholinergic smooth muscle contractions but still viable. J Neurosci 22(24):10627–10632

    Article  CAS  Google Scholar 

  • Romano MC, Doan HK, Poppenga RH, Filigenzi MS, Bryant UK, Gaskill CL (2019) Fatal amanita muscaria poisoning in a dog confirmed by PCR identification of mushrooms. J Vet Diagn Investig 31(3):485–487

    Article  Google Scholar 

  • Wess J (1996) Molecular biology of muscarinic acetylcholine receptors. Crit Rev Neurobiol 10(1):69–99

    Article  CAS  Google Scholar 

  • Yin X, Yang A-A, Gao J-M (2019) Mushroom toxins: chemistry and toxicology. J Agric Food Chem 67(18):5053–5071

    Article  CAS  Google Scholar 

Download references

Author information

Authors and Affiliations

Authors

Corresponding author

Correspondence to Mageshwaran Lakshmanan .

Editor information

Editors and Affiliations

Rights and permissions

Reprints and permissions

Copyright information

© 2021 Springer Nature Singapore Pte Ltd.

About this chapter

Check for updates. Verify currency and authenticity via CrossMark

Cite this chapter

Lakshmanan, M. (2021). Cholinoceptor Agonists and Anticholinesterase Agents. In: Paul, A., Anandabaskar, N., Mathaiyan, J., Raj, G.M. (eds) Introduction to Basics of Pharmacology and Toxicology. Springer, Singapore. https://doi.org/10.1007/978-981-33-6009-9_1

Download citation

Publish with us

Policies and ethics